Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Odyssey Thera

4550 Norris Canyon Road #140
San Ramon, CA 94583
USA
925-242-5000
Website Company Summary Management Team
Management

CEO: John K Westwick (2005)
Technology: Jane Lamerdin
Board

Outside board: (May no longer be on the board) Bryant E Fong (Burrill & Company Managing Director) Alan Sachs (Merck Research Laboratories VP Therapeutics) Hugh Y Rienhoff (DNA Sciences CEO) John H Kim (Burrill & Company Venture Partner) Jeremy Caldwell (Merck Research Laboratories VP Head of RNA Therapeutics) Kleanthis Xanthopoulos (Anadys Pharmaceuticals Managing Director)
Former outside board: Daniel Passeri (Curis CEO)
Company

Business description: Odyssey Therapeutics is a computational immunology company creating innovative therapies for patients with autoimmune diseases. Despite a significant fraction of the aging U.S. population developing an autoimmune disease, the space is underserved and the treatments lacking. Using modern machine learning techniques, Odyssey is transforming the landscape of autoimmune treatments. Everyone has a unique physiology and genetic background. As a result, every autoimmune diagnosis is unique. We use machine learning to design tailored therapies for individuals.
Partners include: Abbott Pfizer;  Dharmacon;  Hoffman-La Roche
Capital

Rounds: 4
Recent Fundings: Feb 2013   Mar 2010
Capital raised: 6.3M
Last Round: 2.8M
Ownership: Private  
VCs include: MerckAndCo. BurrillAndCompany;  HMB Partners;  Health Capital Investors;  Cogene Biotech Ventures
Corporate investors: Incyte;  Lonza

Last Tweets


 

Last Mentions


Overview
Record updated: May 2013
Sector: Medical Devices & Diagnostics
Year Founded: 2018
Headcount: 1-10 as of Oct 2021
Rounds: 4
Recent Fundings: Feb 2013   Mar 2010
Capital Raised: 6.3M
Last Round: 2.8M
Ownership: Private